← All stories
Markets
AstraZeneca (LSE:AZN) Expands Enhertu’s European Treatment Role
Highlights European clearance broadens the treatment setting in which the Enhertu combination can be used. The decision reinforces oncology as a central part of AstraZenecas product and research portfolio. Further regulatory and commercial…
Covered by 1 outlet
All coverage · 1 article